Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

BRIEF Bendamustine and Rituximab In Elderly Follicular

This study has been terminated.
(Treament with rituximab during maintenance phase was stoped, according to DSMC recommendations, since 3 cases of deaths occured.)
Sponsor:
Information provided by (Responsible Party):
The Lymphoma Academic Research Organisation
ClinicalTrials.gov Identifier:
NCT01313611
First received: February 21, 2011
Last updated: May 28, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2014
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)